Skip to main content

Advertisement

SpringerLink
Log in

Advanced larynx cancer

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Despite advances in diagnosis and treatment, the prognosis for patients with stage III–IV laryngeal cancer is not significantly different than it was four decades ago [1]. This failure to improve survival is multifactorial and is likely linked to controversy surrounding optimal treatment regimens for a heterogeneous patient and tumor population. At the root of this controversy is a lack of randomized controlled trials that compare different therapeutic options, personal and institutional treatment philosophies, and a paucity of standardized functional and quality-of-life outcome measures for specific treatment modalities. Therapeutic decision making is further complicated by the potential use of organ preservation approaches in some patients [2··,3·,4··]. Clearly, quality-of-life considerations are an integral part of treatment planning and a well-informed patient is necessary to achieve an optimal result. Philosophically, it is the physician’s responsibility to recommend the best treatment option and to explain the other viable treatment strategies. It is our opinion that conservation laryngeal surgery represents the mainstay of treatment for patients with advanced laryngeal carcinomas, whose tumors have characteristics amenable to these approaches and who functionally can tolerate such procedures. For those patients who would likely require a total laryngectomy or who are not suitable for surgical conservation, organ preservation should be used as a primary option in a controlled setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Hong WK, Lippman SM, Wolf GT: Recent advances in head and neck cancer-larynx preservation and cancer chemoprevention: the seventeenth annual Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 1993, 53:5113–5120.

    PubMed  CAS  Google Scholar 

  2. Forastiere AA, Berkey B, Maor M, et al.: Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup trial R91-11. Proc Am Soc Clin Oncol 2001, 20:2A. The Intergroup trial R91-11 evaluated the effectiveness of primary radiation therapy versus neoadjuvant chemotherapy/ radiation therapy versus concomitant chemotherapy/ radiation therapy. This study demonstrated improvements in laryngectomy-free survival, time to laryngectomy, and larynx preservation when comparing concomitant chemotherapy/ radiation therapy with radiation therapy alone.

    Google Scholar 

  3. Robbins KT, Fontanesi J, Wong FS, et al.: A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg 1996, 122:853–857. Intra-arterial chemotherapy approaches with concomitant radiation therapy have been employed to enhance drug delivery to the tumor site. In this sentinel study, a complete response at the primary site was obtained in 86% of patients and the 2-year overall and disease-specific survival was 64% and 76% respectively.

    PubMed  CAS  Google Scholar 

  4. Wolf GT, Hong WK, Fisher SG, et al.: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991, 325:1685–1690. Until recently, most research focused on neoadjuvant or induction chemotherapy. Although survival has not improved, neoadjuvant chemotherapy/radiation therapy with surgical salvage has resulted in similar survival rates while maintaining an intact, functional larynx in many surviving patients.

    Article  Google Scholar 

  5. Mendenhall WM, Parsons JT, Mancuso AA, et al.: Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck 1996, 1:24–35.

    Article  Google Scholar 

  6. Myers EN, Alvi A: Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends. Laryngoscope 1996, 106:559–567.

    Article  PubMed  CAS  Google Scholar 

  7. Weinstein GS, Laccourreye O, Rassekh C: Conservation laryngeal surgery. In Otolaryngology-and Head Surgery, edn 3. Edited by Cummings CW, Fredrickson JM, Harker LA, et al. St. Louis: Mosby; 1998: 2200–2228. This chapter provides an excellent overview of the various conservation laryngeal procedures.

  8. Iro H, Waldfahrer F, Altendorf-Hofman A, et al.: Transoral laser surgery of supraglottic cancer. Arch Otolaryngol Head Neck Surg 1998, 124:1245–1250.

    PubMed  CAS  Google Scholar 

  9. Bron L, Brossard E, Monnier P, et al.: Supracricoid partial laryngectomy with cricohyoidepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas. Laryngoscope 2000, 110:627–634.

    Article  PubMed  CAS  Google Scholar 

  10. Laccourreye H, Laccourreye O, Weinstein G, et al.: Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas. Laryngoscope 1990, 100:735–741.

    PubMed  CAS  Google Scholar 

  11. Pearson BW, Olsen KD, Desanto LW, et al.: Results of near-total laryngectomy. Ann Otol Rhinol Laryngol 1998, 107:820–825.

    PubMed  CAS  Google Scholar 

  12. Shah JP, Tollefsen HR: Epidermoid carcinoma of the supraglottic larynx. Am J Surg 1994, 128:494–499.

    Article  Google Scholar 

  13. Terrell JE, Fisher SG, Wolf GT: Long-term quality of life after treatment of laryngeal cancer. Arch Otolaryngol Head Neck Surg 1998, 124:964–971.

    PubMed  CAS  Google Scholar 

  14. Laccourreye O, Weinstein G, Naudo P, et al.: Supracricoid partial laryngectomy after failed laryngeal radiation therapy. Laryngoscope 1996, 106:495–498.

    Article  PubMed  CAS  Google Scholar 

  15. Silver CE, Moissa II: The role of surgery in the treatment of laryngeal cancer. CA Cancer J Clin 1990, 403:134–149.

    Article  Google Scholar 

  16. Chevalier D, Laccourreye O, Laccourreye H, et al.: Cricohyoidepiglottopexy for glottic carcinoma with fixation or impaired motion or the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol 1997, 106:364–369.

    PubMed  CAS  Google Scholar 

  17. Mendenhall WM, Parsons JT, Stringer SP, et al.: Stage 3 squamous cell carcinoma of the glottic larynx: a comparison of laryngectomy and irradiation. Int J Radiat Oncol Biol Phy 1992, 23:725–732.

    Article  CAS  Google Scholar 

  18. Parsons JT, Mendenhall WM, Mancuso AA, et al.: Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx. Head Neck 1989, 11:123–127.

    Article  PubMed  CAS  Google Scholar 

  19. DeSanto LW: T3 glottic cancer: options and consequences of the options. Laryngoscope 1984, 94:1311–1325.

    Article  PubMed  CAS  Google Scholar 

  20. Foote RL, Olsen KD, Buskirk SJ, et al.: Laryngectomy alone for T3 glottic cancer. Head Neck 1994, 16:406–412.

    Article  PubMed  CAS  Google Scholar 

  21. Yuen A, Medina JE, Goepfert H, et al.: Management of stage T3 and T4 glottic carcinomas. Am J Surg 1984, 148:467–472.

    Article  PubMed  CAS  Google Scholar 

  22. Schuller DE, Bier-Laning CM: Laryngeal carcinoma nodal metastases and their management. Otolarynol Clin North Am 1997, 30:167–176.

    CAS  Google Scholar 

  23. Myers EN, Fagan JJ: Management of the neck in cancer of the larynx. Ann Otol Rhinol Laryngol 1999, 108:828–832.

    PubMed  CAS  Google Scholar 

  24. Razack MS, Maipang T, Bakamjian SK, et al.: Management of advanced glottic carcinomas. Am J Surg 1989, 158:318–319.

    Article  PubMed  CAS  Google Scholar 

  25. Terhaard CHJ, Hordijk GJ, Ravasz LA: Treatment of advanced laryngeal cancer (T3-4). Acta Otorhinolaryngol Belg 1992, 46:197–212.

    PubMed  CAS  Google Scholar 

  26. Mendenhall WM, Parsons JT, Mancuso, et al.: Definitive radiatiotherapy for T3 squamous cell carcinoma of the glottic larynx. J Clin Oncol 1997, 15:2394–2402.

    PubMed  CAS  Google Scholar 

  27. Mendenhall WM: T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone. Semin Rad Onc 1998, 8:262–269.

    Article  CAS  Google Scholar 

  28. Parsons JT, Mendenhall WM, Stringer SP, et al.: T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys 1998, 40:549–552.

    Article  PubMed  CAS  Google Scholar 

  29. Carew JF, Shah JP: Advances in multimodality therapy for laryngeal cancer. CA Cancer J Clin 1998, 48:211–228.

    PubMed  CAS  Google Scholar 

  30. Lewis JE, Olsen KD, Inwards CY: Cartilaginous tumors of the larynx: clinicopathologic review of 47 cases. Ann Otol Rhinol Laryngol 1997, 106:94–100.

    PubMed  CAS  Google Scholar 

  31. Friedlander PL, Lyons GD: Chondrosarcoma of the larynx. Otolaryngol Head Neck Surg 2000, 122:617.

    Article  PubMed  CAS  Google Scholar 

  32. Robin PE, Rockley T, Powell DJ, et al.: Survival of cancer of the larynx related to treatment. Clin Otolaryngol 1991, 16:193–197.

    PubMed  CAS  Google Scholar 

  33. Strome S, Robey T, Devaney K, et al.: Subglottic carcinoma: review of a series and characterization of its patterns of spread. Ear Nose Throat 1999, 78:622–632.

    CAS  Google Scholar 

  34. Kirchner JA: Transglottic cancer. In Atlas on the Surgical Anatomy of Laryngeal Cancer. San Diego, CA: Singular Publishing Group; 1998:61–77. This text demonstrates the patterns of tumor spread in laryngeal cancer and provides further justification for many, if not all, of the surgical procedures performed currently.

    Google Scholar 

  35. Pillsbury HA, Kirchner JA: Clinical vs. histopathologic staging in laryngeal cancer. Arch Otolaryngol Head Neck Surg 1979, 105:157–159.

    CAS  Google Scholar 

  36. Hoa SP, Myers EN, Johnson JT: T3 glottic carcinoma revisited. Transglottic vs. pure glottic carcinoma. Arch Otolaryngol Head Neck Surg 1995, 121:166–170.

    Google Scholar 

  37. Mittal B, Marks JE, Ogura JH: Transglottic carcinoma. Cancer 1984, 53:151–161.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, Mayo Clinic, 200 First Street SW, 55906, Rochester, MN, USA

    Scott E. Strome MD & Eric C. Weinman MD

Authors
  1. Scott E. Strome MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric C. Weinman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strome, S.E., Weinman, E.C. Advanced larynx cancer. Curr. Treat. Options in Oncol. 3, 11–20 (2002). https://doi.org/10.1007/s11864-002-0037-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-002-0037-9

Keywords

Search

Navigation